ProfileGDS4459 / ENSG00000183495
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 65% 63% 66% 57% 62% 64% 68% 64% 64% 63% 60% 67% 68% 55% 65% 59% 63% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.9865
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.8763
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.1366
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.7357
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.962
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.9764
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.3268
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.9864
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.0464
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.9863
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.6860
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.1967
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.2368
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.5955
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.0865
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.7159
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.8663